Literature DB >> 6358261

Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.

D M Shoback, G H Williams, T J Moore, R G Dluhy, S Podolsky, N K Hollenberg.   

Abstract

In normal subjects, dietary sodium intake modulates renovascular, adrenal, and pressor responses to infused angiotensin II (AII). To examine the hypothesis that this modulation is abnormal in some patients with essential hypertension, we studied 18 hypertensives and 9 normal subjects twice--during dietary sodium restriction and during loading. Paraaminohippurate (PAH) clearance was used to assess renal plasma flow. AII was infused in graded doses (0.3-3.0 ng/kg per min). Plasma aldosterone, cortisol, renin activity, AII, sodium, potassium, and PAH clearance were measured at the onset and end of each AII dose. During dietary sodium repletion, eight of the subjects with essential hypertension showed a normal renovascular response (greater than 125 ml/min per 1.73 m2) to AII infusion (3 ng/kg per min). The decrement in renal blood flow in these normal responders (NR) was 168 +/- 10, which was comparable to the range in normotensive subjects (206 +/- 25 ml/min per 1.73 m2). All of the remaining hypertensive patients, designated abnormal responders (AbR), had lower (less than 125) renal blood flow responses to the same dose of infused AII (mean decrement: 84 +/- 11 ml/min per 1.73 m2) compared with the NR and normotensive subjects. Renal blood flow responses to all AII doses were statistically greater on a high-vs.-low salt diet in the NR (P less than 0.001, chi-square) and normotensives (P = 0.004, chi-square) but sodium intake had no effect on this response in the AbR. Basal renal blood flow in NR increased significantly (P less than 0.001, paired t test) with dietary sodium repletion, from 491 +/- 36 (low salt) to 602 +/- 40 ml/min per 1.73 m2 (high salt), but was almost identical in the AbR on differing dietary sodium intakes (429 +/- 24 vs. 425 +/- 26 ml/min per 1.73 m2). The adrenal responses to sodium intake and infused AII also differed in the two subgroups. In the NR, the adrenal response to AII was significantly greater (P = 0.011, Wilcoxon signed rank test) after sodium restriction. In contrast, there was no significant difference in the aldosterone response to AII infusion between the low and high sodium diets in the AbR. Thus, a substantial subgroup of essential hypertensives has an abnormality in responsiveness to AII in two systems central to volume homeostasis: the kidney and adrenal. They fail to modulate their renal blood flow and aldosterone responses to AII with changes in dietary sodium intake. Moreover, basal renal blood flow does not increase appropriately with increased sodium intake. These abnormalities, which may be due to an increased local production of AII or a defect in the AII receptors in these three target tissues, could contribute to the elevated blood pressure.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6358261      PMCID: PMC437052          DOI: 10.1172/JCI111176

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  THE MEASUREMENT OF THE TUBULAR EXCRETORY MASS, EFFECTIVE BLOOD FLOW AND FILTRATION RATE IN THE NORMAL HUMAN KIDNEY.

Authors:  H W Smith; W Goldring; H Chasis
Journal:  J Clin Invest       Date:  1938-05       Impact factor: 14.808

2.  Influence of sodium intake on vascular and adrenal angiotensin II receptors.

Authors:  G H Williams; N K Hollenberg; L M Braley
Journal:  Endocrinology       Date:  1976-06       Impact factor: 4.736

3.  Altered renin-angiotensin-aldosterone relationships in normal renin essential hypertension.

Authors:  T J Moore; G H Williams; R G Dluhy; S Z Bavli; T Himathongkam; M Greenfield
Journal:  Circ Res       Date:  1977-08       Impact factor: 17.367

4.  The metabolic clearance of aldosterone decreases similarly during infusion of angiotensin II in patients with essential hypertension and in normal subjects.

Authors:  M Wisgerhof; R D Brown
Journal:  J Clin Endocrinol Metab       Date:  1979-07       Impact factor: 5.958

5.  The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis.

Authors:  R H Underwood; G H Williams
Journal:  J Lab Clin Med       Date:  1972-05

6.  Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man.

Authors:  G H Williams; N K Hollenberg; C Brown; J H Mersey
Journal:  J Clin Endocrinol Metab       Date:  1978-10       Impact factor: 5.958

7.  Sodium intake and renal responses to captopril in normal man and in essential hypertension.

Authors:  N K Hollenberg; L G Meggs; G H Williams; J Katz; J D Garnic; D P Harrington
Journal:  Kidney Int       Date:  1981-08       Impact factor: 10.612

8.  A delayed suppression of the renin-aldosterone axis following saline infusion in human hypertension.

Authors:  M L Tuck; G H Williams; R G Dluhy; M Greenfield; T J Moore
Journal:  Circ Res       Date:  1976-11       Impact factor: 17.367

9.  Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man.

Authors:  N K Hollenberg; W R Chenitz; D F Adams; G H Williams
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

10.  Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.

Authors:  R G Dluhy; S Z Bavli; F K Leung; H S Solomon; T J Moore; N K Hollenberg; G H Williams
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

View more
  35 in total

1.  Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease.

Authors:  Duncan J Campbell; Habib Karam; Patrick Bruneval; John J Mullins; Joël Ménard
Journal:  J Hypertens       Date:  2010-07       Impact factor: 4.844

Review 2.  Mechanisms of hypertension: the expanding role of aldosterone.

Authors:  E Marie Freel; John M C Connell
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

3.  Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.

Authors:  Anand Vaidya; Bei Sun; Carol Larson; John P Forman; Jonathan S Williams
Journal:  J Clin Endocrinol Metab       Date:  2012-04-26       Impact factor: 5.958

4.  President's address: salt-too much of a good thing?

Authors:  Robert G Luke
Journal:  Trans Am Clin Climatol Assoc       Date:  2007

5.  Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans.

Authors:  John P Forman; Jonathan S Williams; Naomi D L Fisher
Journal:  Hypertension       Date:  2010-03-29       Impact factor: 10.190

Review 6.  Nutritional aspects of pediatric hypertension.

Authors:  J R Ingelfinger
Journal:  Bull N Y Acad Med       Date:  1989-12

7.  Altered systemic hemodynamic and baroreflex response to angiotensin II in postural tachycardia syndrome.

Authors:  Hossam I Mustafa; Satish R Raj; André Diedrich; Bonnie K Black; Sachin Y Paranjape; William D Dupont; Gordon H Williams; Italo Biaggioni; David Robertson
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-13

8.  Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension.

Authors:  A Vaidya; J P Forman; J S Williams
Journal:  J Hum Hypertens       Date:  2010-12-02       Impact factor: 3.012

9.  Dysregulated aldosterone secretion in persons of African descent with endothelin-1 gene variants.

Authors:  Jia W Tan; Tina Gupta; Worapaka Manosroi; Tham M Yao; Paul N Hopkins; Jonathan S Williams; Gail K Adler; Jose R Romero; Gordon H Williams
Journal:  JCI Insight       Date:  2017-12-07

10.  Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension.

Authors:  Kimberly Gilbert; Hui Nian; Chang Yu; James M Luther; Nancy J Brown
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.